Found: 89
Select item for more details and to access through your institution.
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfate.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Lactic Acidosis in Lymphoma: Prompt Resolution of Acidosis With Therapy Directed at the Lymphoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 13, p. 1077
- By:
- Publication type:
- Article
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
- Published in:
- 2017
- By:
- Publication type:
- journal article
HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2¯ Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group.
- Published in:
- Clinical Breast Cancer, 2011, v. 11, n. 4, p. 228, doi. 10.1016/j.clbc.2011.04.001
- By:
- Publication type:
- Article
Ixabepilone: Clinical Role in Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2011, v. 11, n. 3, p. 139, doi. 10.1016/j.clbc.2011.03.009
- By:
- Publication type:
- Article
CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 489, doi. 10.3816/CBC.2010.n.065
- By:
- Publication type:
- Article
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 243, doi. 10.1007/s10549-023-06881-8
- By:
- Publication type:
- Article
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 3, p. 571, doi. 10.1007/s10549-022-06743-9
- By:
- Publication type:
- Article
Molecular characterization of ESR1 variants in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 2, p. 279, doi. 10.1007/s10549-022-06740-y
- By:
- Publication type:
- Article
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 3, p. 555, doi. 10.1007/s10549-021-06417-y
- By:
- Publication type:
- Article
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 179, doi. 10.1007/s10549-021-06103-z
- By:
- Publication type:
- Article
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 863, doi. 10.1007/s10549-020-06053-y
- By:
- Publication type:
- Article
Risk factors for inflammatory and non-inflammatory breast cancer in North Africa.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 2, p. 543, doi. 10.1007/s10549-020-05864-3
- By:
- Publication type:
- Article
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 2, p. 265, doi. 10.1007/s10549-020-05849-2
- By:
- Publication type:
- Article
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 389, doi. 10.1007/s10549-019-05398-3
- By:
- Publication type:
- Article
Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 2, p. 407, doi. 10.1007/s10549-019-05237-5
- By:
- Publication type:
- Article
Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1139347
- By:
- Publication type:
- Article
Cardiac Dysfunction after Cancer Treatment.
- Published in:
- Texas Heart Institute Journal, 2011, v. 38, n. 3, p. 248
- By:
- Publication type:
- Article
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 7, p. 1853, doi. 10.1245/s10434-016-5662-9
- By:
- Publication type:
- Article
NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2013, v. 2013, p. 1, doi. 10.1155/2013/964592
- By:
- Publication type:
- Article
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics data.
- Published in:
- BMC Bioinformatics, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12859-024-05835-1
- By:
- Publication type:
- Article
Pertuzumab: Increasing the Options.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 3, p. 199
- By:
- Publication type:
- Article
Defining the IBC Phenotype.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 14, p. 1566
- By:
- Publication type:
- Article
Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 5, p. 1, doi. 10.1093/jncics/pkaa058
- By:
- Publication type:
- Article
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00265-1
- By:
- Publication type:
- Article
Video intervention increases participation of black breast cancer patients in therapeutic trials.
- Published in:
- NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0039-1
- By:
- Publication type:
- Article
RESPONSE.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Ductal carcinoma in situ, complexities and challenges.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Re: Tamoxifen and contralateral breast cancer: the other side.
- Published in:
- 2001
- By:
- Publication type:
- Letter
Tamoxifen and contralateral breast cancer: the other side.
- Published in:
- 2001
- By:
- Publication type:
- commentary
Tamoxifen: the long and short of it.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1996, v. 88, n. 21, p. 1510, doi. 10.1093/jnci/88.21.1516
- By:
- Publication type:
- Article
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel Targets.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1855, doi. 10.3390/cancers15061855
- By:
- Publication type:
- Article
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5051, doi. 10.3390/cancers14205051
- By:
- Publication type:
- Article
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2596, doi. 10.3390/cancers14112596
- By:
- Publication type:
- Article
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2262, doi. 10.3390/cancers13092262
- By:
- Publication type:
- Article
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1566, doi. 10.3390/cancers13071566
- By:
- Publication type:
- Article
Phase II study of oral etoposide for patients with advanced breast cancer.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 1, p. 63, doi. 10.1007/s10637-006-9006-7
- By:
- Publication type:
- Article
Take care of your neighborhood.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 225, doi. 10.1007/s10549-017-4492-1
- By:
- Publication type:
- Article
Genomic profiling of breast cancer in African-American women using MammaPrint.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 159, n. 3, p. 481, doi. 10.1007/s10549-016-3949-y
- By:
- Publication type:
- Article
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 2, p. 235, doi. 10.1007/s10549-015-3673-z
- By:
- Publication type:
- Article
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 2, p. 285, doi. 10.1007/s10549-016-3678-2
- By:
- Publication type:
- Article
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA).
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 142, n. 1, p. 89, doi. 10.1007/s10549-013-2710-z
- By:
- Publication type:
- Article
Twenty-five year results of the national cancer institute randomized breast conservation trial.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 1, p. 197, doi. 10.1007/s10549-011-1867-6
- By:
- Publication type:
- Article
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 119, n. 3, p. 685, doi. 10.1007/s10549-009-0651-3
- By:
- Publication type:
- Article